SINTX regains Nasdaq compliance with sufficient stockholders' equity

SINTX Technologies Inc. said on Monday it had regained compliance with Nasdaq's minimum stockholders' equity requirement, ending a period of uncertainty for the biotech firm.

The company's shares were temporarily halted prior to the announcement as it confirmed it had met the exchange's listing standards. Nasdaq requires listed companies to maintain a minimum level of stockholders' equity to remain compliant.

SINTX did not disclose the specific equity figure or the duration of the compliance review. The company added that it remains focused on advancing its pipeline of medical device and diagnostic technologies, including its silicon nitride-based platform.

The compliance status is critical for SINTX, which has faced challenges in recent years, including operational and financial constraints. Regaining Nasdaq compliance may improve investor confidence and provide greater access to capital markets.

SINTX's stock was last trading at $0.15 before the halt, according to market data. The company has not provided an updated trading status following the announcement.

For now, SINTX's compliance with Nasdaq's equity requirement removes an immediate risk of delisting, though the firm continues to navigate a competitive and capital-intensive sector.